167 related articles for article (PubMed ID: 25228395)
1. Tissue factor expression on the surface of monocytes from a patient with hereditary angioedema.
Iwamoto K; Morioke S; Yanase Y; Uchida K; Hide M
J Dermatol; 2014 Oct; 41(10):929-32. PubMed ID: 25228395
[TBL] [Abstract][Full Text] [Related]
2. Changes of coagulation parameters during erythema marginatum in patients with hereditary angioedema.
Kőhalmi KV; Mező B; Veszeli N; Benedek S; Fehér A; Holdonner Á; Jesenak M; Varga L; Farkas H
Int Immunopharmacol; 2020 Apr; 81():106293. PubMed ID: 32078942
[TBL] [Abstract][Full Text] [Related]
3. The role of ficolins and MASPs in hereditary angioedema due to C1-inhibitor deficiency.
Csuka D; Munthe-Fog L; Skjoedt MO; Kocsis A; Zotter Z; Gál P; Varga L; Farkas H; Füst G; Garred P
Mol Immunol; 2013 Jul; 54(3-4):271-7. PubMed ID: 23318225
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormones and complement parameters in hereditary angioedema with C1-inhibitor deficiency.
Czaller I; Csuka D; Zotter Z; Veszeli N; Takács E; Imreh É; Varga L; Farkas H
Ann Allergy Asthma Immunol; 2016 Aug; 117(2):175-9. PubMed ID: 27364943
[TBL] [Abstract][Full Text] [Related]
5. Novel Vasoregulatory Aspects of Hereditary Angioedema: the Role of Arginine Vasopressin, Adrenomedullin and Endothelin-1.
Kajdácsi E; Jani PK; Csuka D; Varga L; Prohászka Z; Farkas H; Cervenak L
J Clin Immunol; 2016 Feb; 36(2):160-70. PubMed ID: 26873707
[TBL] [Abstract][Full Text] [Related]
6. Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency.
Cugno M; Zanichelli A; Bellatorre AG; Griffini S; Cicardi M
Allergy; 2009 Feb; 64(2):254-7. PubMed ID: 19076541
[TBL] [Abstract][Full Text] [Related]
7. Hereditary angioedema attack: what happens to vasoactive mediators?
Ferrara AL; Bova M; Petraroli A; Veszeli N; Galdiero MR; Braile M; Marone G; Cristinziano L; Marcella S; Modestino L; Farkas H; Loffredo S
Int Immunopharmacol; 2020 Jan; 78():106079. PubMed ID: 31841756
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell activation during edematous attacks of hereditary angioedema types I and II.
Kajdácsi E; Jani PK; Csuka D; Varga LÁ; Prohászka Z; Farkas H; Cervenak L
J Allergy Clin Immunol; 2014 Jun; 133(6):1686-91. PubMed ID: 24522092
[TBL] [Abstract][Full Text] [Related]
9. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor.
Moreno AS; Valle SO; Levy S; França AT; Serpa FS; Arcuri HA; Palma MS; Campos WN; Dias MM; Ponard D; Monnier N; Lunardi J; Bork K; Silva WA; Arruda LK
Int Arch Allergy Immunol; 2015; 166(2):114-20. PubMed ID: 25790805
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of hereditary angioedema.
Canonica GW; Rossi O
Panminerva Med; 2012 Sep; 54(3):241-53. PubMed ID: 22801442
[TBL] [Abstract][Full Text] [Related]
11. Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
Kajdácsi E; Jandrasics Z; Veszeli N; Makó V; Koncz A; Gulyás D; Köhalmi KV; Temesszentandrási G; Cervenak L; Gál P; Dobó J; de Maat S; Maas C; Farkas H; Varga L
Front Immunol; 2020; 11():794. PubMed ID: 32431708
[TBL] [Abstract][Full Text] [Related]
12. Activation of the ficolin-lectin pathway during attacks of hereditary angioedema.
Csuka D; Munthe-Fog L; Hein E; Zotter Z; Prohászka Z; Farkas H; Varga L; Garred P
J Allergy Clin Immunol; 2014 Dec; 134(6):1388-1393.e1. PubMed ID: 25042985
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
Kaplan AP; Joseph K
Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
[TBL] [Abstract][Full Text] [Related]
14. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
[TBL] [Abstract][Full Text] [Related]
15. Lack of increased prevalence of immunoregulatory disorders in hereditary angioedema due to C1-inhibitor deficiency.
Farkas H; Csuka D; Gács J; Czaller I; Zotter Z; Füst G; Varga L; Gergely P
Clin Immunol; 2011 Oct; 141(1):58-66. PubMed ID: 21636327
[TBL] [Abstract][Full Text] [Related]
16. A novel assay to diagnose hereditary angioedema utilizing inhibition of bradykinin-forming enzymes.
Joseph K; Bains S; Tholanikunnel BG; Bygum A; Aabom A; Koch C; Farkas H; Varga L; Ghebrehiwet B; Kaplan AP
Allergy; 2015 Jan; 70(1):115-9. PubMed ID: 25186184
[TBL] [Abstract][Full Text] [Related]
17. Shortened Activated Partial Thromboplastin Time May Help in Diagnosing Hereditary and Acquired Angioedema.
Bork K; Witzke G
Int Arch Allergy Immunol; 2016; 170(2):101-7. PubMed ID: 27463190
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.
Moellman JJ; Bernstein JA
J Emerg Med; 2012 Aug; 43(2):391-400. PubMed ID: 22285754
[TBL] [Abstract][Full Text] [Related]
19. Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk.
Reshef A; Zanichelli A; Longhurst H; Relan A; Hack CE
Allergy; 2015 May; 70(5):506-13. PubMed ID: 25640891
[TBL] [Abstract][Full Text] [Related]
20. Activation of the coagulation cascade in C1-inhibitor deficiencies.
Cugno M; Cicardi M; Bottasso B; Coppola R; Paonessa R; Mannucci PM; Agostoni A
Blood; 1997 May; 89(9):3213-8. PubMed ID: 9129025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
